Jasper Therapeutics Inc.
Organization details
- Legal name
- Jasper Therapeutics Inc.
- Former names
- Amplitude Healthcare Acquisition Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Redwood City
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- JSPR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001788028
- EIN
- 84-2984849
Board of directors
-
Anna Louise French · DirectorSince 2023
-
Chris Nolet · DirectorSince 2023
-
Jeetinder Singh Mahal · Director · CEO and PresidentSince 2026
-
Judith Anne Shizuru · DirectorSince 2023
-
Kurt Von Emster · DirectorSince 2023
-
Lawrence Otto Klein · DirectorSince 2023
-
Patrick J. Crutcher · DirectorSince 2026
-
Ron Martell · Director · President, CEO and DirectorSince 2023
-
Scott C. Brun · DirectorSince 2023
-
Svetlana Lucas · DirectorSince 2024
-
Thomas G. Wiggans · DirectorSince 2023
-
Vishal Kapoor · DirectorSince 2023
-
William Lis · DirectorSince 2023
Chief executives
Director election results
Annual meeting of July 31, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.7%
-
95.7%
Board connections
8 of this board's directors also sit on 10 other boards. 9 are in the same sector.
- via Patrick J. Crutcher
-
Annexon Inc. Same sectorvia Thomas G. Wiggans
-
ArriVent BioPharma Inc. Same sectorvia Chris Nolet
-
Cabaletta Bio Inc. Same sectorvia Scott C. Brun
-
Iambic Therapeutics Inc. Same sectorvia Kurt Von Emster
-
Jade Biosciences Inc. Same sectorvia Lawrence Otto Klein
-
Oruka Therapeutics Inc. Same sectorvia Lawrence Otto Klein
-
Pacira BioSciences Inc. Same sectorvia Thomas G. Wiggans
-
Zai Lab Limited Same sectorvia William Lis
-
aTyr Pharma Inc. Same sectorvia Svetlana Lucas
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2025 | Thomas G. Wiggans Director | Open-market purchase | +41,000 | $2.43 | $99,630 |
| Sep 22, 2025 | Svetlana Lucas Director | Open-market purchase | +20,000 | $2.43 | $48,600 |
| Sep 22, 2025 | Ron Martell Director, Officer (President and CEO) | Open-market purchase | +41,000 | $2.43 | $99,630 |
| Sep 22, 2025 | Judith Anne Shizuru Director | Open-market purchase | +41,000 | $2.43 | $99,630 |
| Dec 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Option exercise | +900 | $7.10 | $6,390 |
| Dec 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Open-market sale | −900 | $22.11 | $19,899 |
| Sep 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Option exercise | +900 | $7.10 | $6,390 |
| Sep 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Open-market sale | −900 | $21.23 | $19,107 |
| Jun 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Option exercise | +900 | $7.10 | $6,390 |
| Jun 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Open-market sale | −900 | $24.16 | $21,744 |
| Jun 7, 2024 | Tucker Edwin Jonathan Officer (Chief Medical Officer) | Grant or award | +400 | $4.17 | $1,668 |
| Mar 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Option exercise | +900 | $7.10 | $6,390 |
| Mar 12, 2024 | Mahal Jeetinder Singh Officer (Chief Operating Officer) | Open-market sale | −900 | $26.44 | $23,796 |
| Feb 8, 2024 | Abingworth LLP 10% owner | Open-market purchase | +190,000 | $12.95 | $2,460,500 |
| Feb 8, 2024 | VENKATARAMAN BALAJI 10% owner | Open-market purchase | +350,000 | $12.95 | $4,532,500 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Jasper Therapeutics Inc.
Who is the CEO of Jasper Therapeutics Inc.?
Ron Martell is Jasper Therapeutics Inc.'s President, CEO and Director.
How many directors are on Jasper Therapeutics Inc.'s board?
Jasper Therapeutics Inc.'s board has 13 directors: Anna Louise French, Chris Nolet, Jeetinder Singh Mahal, Judith Anne Shizuru, Kurt Von Emster, Lawrence Otto Klein, Patrick J. Crutcher, Ron Martell, Scott C. Brun, Svetlana Lucas and 3 others.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="jasper-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.